[HTML][HTML] Efficacy of levofloxacin-based third-line therapy for the eradication of Helicobacter pylori in peptic ulcer disease

JH Lim, SG Kim, JH Song, JJ Hwang, DH Lee… - Gut and …, 2017 - ncbi.nlm.nih.gov
Methods Between 2002 and 2014, 110 patients in 14 medical centers received levofloxacin-
based third-line H. pylori eradication therapy for peptic ulcer disease. Of these, 88 were …